GENE THERAPY — EVOLVED
The Gene Coding Company
The Gene Coding Approach
SalioGen is advancing a new category of genetic medicine we call Gene Coding. Gene Coding works by adding a new genomic code to turn on, off or modify function of new or existing genes. Our Gene Coding approach is guided by our Exact DNA Integration Technology (EDIT) platform, a genome engineering technology that leverages proprietary mammal-derived enzymes we call Saliogase. With broad applicability, non-viral delivery capabilities of any size gene and significant manufacturing advantages, EDIT has the potential to transform the treatment paradigm for inherited disorders and beyond.
Our Gene Coding Therapeutic Pipeline
We are advancing potentially curative therapies, with an initial focus on developing durable, safe and accessible genetic medicine to more patients with inherited disorders. Looking ahead, SalioGen plans to explore our platform’s capabilities to streamline cell therapy, cell engineering, and biologics manufacturing with the goal of helping an even broader population of patients in need.
We are driven not only by our efforts to realize the immense potential of our science, but also by our dedication and commitment to developing medicines that can make a significant impact on patients’ lives.
Press Releases, Media Coverage & More
Find our press releases and media coverage.
Join Our Team
Join our team of leading scientists, expert drug developers, and biotech industry veterans. Together, we are working to transform the treatment landscape of genetic disorders.
Get In Touch
Contact us to learn more about SalioGen’s unique approach to genetic medicine.